New Medical Device Integrations at CRF Health
CRF Health
announced new medical device integrations to support both spirometers and glucometers used in Phase I-IV respiratory and diabetes clinical trials. CRF Health’s eDiary TrialMax® platform now integrates with Entra Health Systems’ Bluetooth-enabled MyGlucoHealth Wireless Meter and Vitalograph’s Asma-1 electronic Peak Flow Meter.
The wireless integration of our eDiaries with these medical devices results in more accurate data by removing the need for manual transcription of the data values. The date and time stamp of the reading and the device serial number are also transferred, providing evidence of the timeliness of the data and an attributable source. Once the eDiary receives the values from the glucometer or PEF meter, the values can automatically be sent to the ePRO database for review by the site personnel or study team. This allows very close to real-time monitoring of the subject’s status and permits timely intervention for safety or compliance concerns.
Benefits for clinical trial Sponsors include:
· Near real time access to all patient-generated data
· Defensible data that meets the FDA’s ALCOA standard
· Ease of use – no wires or cradles to connect
· High compliance to protocol (reminder alerts)
· No data transcription errors
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
